Srdan Verstovsek, MD, PhD, of The University of Texas MD Anderson Cancer Center, Houston, TX, explores the next steps in the treatment and management of myeloproliferative neoplasms (MPNs), including focusing on prevention of disease progression, life extension, as well as improving quality of life in patients with MPNs. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).